Kirsten Bibbins-Domingo

Kirsten Bibbins-Domingo, a physician-scientist and Editor-in-Chief of JAMA, joins Jennifer Abbasi to unveil the journal's Research of the Year. They explore significant topics such as groundbreaking studies on hypertension and heart failure, the impact of lifestyle interventions on cognitive decline, and the benefits of real-world evidence in clinical trials. Kirsten also highlights a crucial shingles vaccine study linked to dementia and discusses the implications of AI in healthcare research. Their insights provide a fascinating glimpse into the year's most impactful findings.

JAMA Editor in Chief and a professor of pediatrics discuss how AI can reduce clinician burden and streamline health systems. Topics include AI in the back office of healthcare, types of studies needed in AI and clinical practice, equitable considerations in applying new technologies, and transforming electronic health records with AI.

JAMA Editor in Chief Kirsten Bibbins-Domingo and UCSF's Chief Research Informatics Officer Ida Sim discuss the transformative potential of AI in medicine, exploring generative AI and large language models. They reflect on AI augmentation in medicine and the importance of AI in medical practice. The potential role of AI in clinical practice is also explored, emphasizing the need for collaboration between computer science and medical professionals in AI innovation.

Kirsten Bibbins-Domingo, an esteemed editor in chief of a prominent medical journal, dives into groundbreaking topics. She discusses the implications of aspirin discontinuation during pregnancy to mitigate preterm preeclampsia risks. The genetic link between APOE variants and Alzheimer's disease in African ancestry populations is examined, highlighting critical health disparities. Additionally, there’s an analysis of low wages correlating with increased mortality and an emphasis on innovative insulin pricing in California, alongside a reevaluation of sepsis management and the prevalence of brain malignancies.

Kirsten Bibbins-Domingo, a physician-scientist and Editor-in-Chief of JAMA, joins Jennifer Abbasi to delve into groundbreaking research from the past year. They explore the Laryngostat trial that successfully reduced blood pressure in treatment-resistant hypertension. Kirsten also discusses the promising results of GLP-1s in heart failure, a shingles vaccine's link to lower dementia risk, and a hepatitis B vaccine trail in HIV patients. Plus, they highlight lifestyle interventions that may boost cognition in older adults and the implications of a new trial on transfusion thresholds.